' Great Optimism ' Over Complete Responses in dMMR Rectal Cancer ' Great Optimism ' Over Complete Responses in dMMR Rectal Cancer

A small trial shows that patients with locally advanced rectal cancer and deficient mismatch repair tumors respond remarkably well to neoadjuvant PD-1 blockade with dostarlimab.Medscape Medical News
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Hematology-Oncology News Source Type: news